Dianthus Therapeutics, Inc. /DE/ ($DNTH)
Filing Information
| Accession Number | 0001273351-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 18, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
60,000
Total Value
$2,385,245.70
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF ACCOUNTING OFFICER | Common Stock | โ | Sep 17, 2026 | Exercise/Conversion | 20,000 | $17.88 | $357,600.00 | 20,000 | Direct | โ | View Details | |
CHIEF ACCOUNTING OFFICER | Common Stock | โ | Sep 17, 2026 | Sale | 7,928 | $100.43 | $796,209.04 | 12,072 | Direct | โ | View Details | |
CHIEF ACCOUNTING OFFICER | Common Stock | โ | Sep 17, 2026 | Sale | 6,771 | $101.37 | $686,376.27 | 5,301 | Direct | โ | View Details | |
CHIEF ACCOUNTING OFFICER | Common Stock | โ | Sep 17, 2026 | Sale | 3,501 | $102.39 | $358,467.39 | 1,800 | Direct | โ | View Details | |
CHIEF ACCOUNTING OFFICER | Common Stock | โ | Sep 17, 2026 | Sale | 1,100 | $103.20 | $113,520.00 | 700 | Direct | โ | View Details | |
CHIEF ACCOUNTING OFFICER | Common Stock | โ | Sep 17, 2026 | Sale | 700 | $104.39 | $73,073.00 | 0 | Direct | โ | View Details | |
CHIEF ACCOUNTING OFFICER | Stock Option (Right to Buy) | Derivative | Sep 17, 2026 | Exercise/Conversion | 20,000 | $0.00 | $0.00 | 43,818 | Direct | โ | View Details |